Norfalk develops bio-based surfactants via biocatalysis for products from shampoos to detergents. CEO Kasper Falkenberg shares the company’s vision, motivation, and the value of its unique platform.
June 23, 2026 | Explore how AI-driven materials informatics is reshaping polymer development, as industry leaders reveal practical strategies for scaling digital platforms and accelerating innovation.
In this CHEManager Leaders & Motivators interview, Frank Romanski, Lonza Capsugel, reflects on how strategy becomes execution and what resilience demands from teams,
REEcover recovers rare earths from e‑waste using a patented, efficient, low‑impact process, offering a sustainable alternative to mining and strengthening circular supply chains.
Newsletter & e-edition
News, trends and background information as well as the latest issue of CHEManager International
29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.
CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.
DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.
Since 2021, the Swiss Biotech Day has become a premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships.
The Pharma Partnering EU Summit 2026 will take place in Basel, Switzerland, on May 20–21, 2026, bringing together global leaders in business development and licensing from pharmaceutical and biotech organizations.
Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
